Adrenomedullin for biologic-resistant Crohn's disease: A randomized, double-blind, placebo-controlled phase 2a clinical trial.
Kita T, Ashizuka S, Takeda T, Matsumoto T, Ohmiya N, Nakase H, Motoya S, Ohi H, Mitsuyama K, Hisamatsu T, Kanmura S, Kato N, Ishihara S, Nakamura M, Moriyama T, Saruta M, Nozaki R, Yamamoto S, Inatsu H, Watanabe K, Kitamura K.
Kita T, et al. Among authors: inatsu h.
J Gastroenterol Hepatol. 2022 Nov;37(11):2051-2059. doi: 10.1111/jgh.15945. Epub 2022 Jul 25.
J Gastroenterol Hepatol. 2022.
PMID: 35840351
Free PMC article.
Clinical Trial.